ONCOVIR CANADA INC: federal grants and contributions: 2 agreements; $4.2M value; 1 departments; 2 programs.
Assay record ASY-CA-08U5KK51YX · Cite as: Assay Systems, “ONCOVIR CANADA INC: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/oncovir-canada-inc/
The overall goal of this project is to advance the clinical development of Poly-ICLC (Hiltonol®), a broad-spectrum antiviral drug candidate, as an innovative solution to strengthen medical preparedness against viral threats.
Develop immunoassay kits that can measure all three classes of SARS-CoV-2 antibodies simultaneously or individually.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.